Shuli Li

E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group

Shanthi Marur, Shuli Li, Anthony J. Cmelak et al. · Journal of Clinical Oncology · 2017 · 504 citations

Medicine, Oncology, Radiation Oncology +14

Anatomically distinct fibroblast subsets determine skin autoimmune patterns

Zijian Xu, Daoming Chen, Yucheng Hu et al. · Nature · 2021 · 330 citations

Life Sciences, Cell Biology, Immunology +14

Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF^V600E</i> Mutations: Results of the NCI-MATCH Trial Subprotocol H

April K.S. Salama, Shuli Li, Erin Macrae et al. · Journal of Clinical Oncology · 2020 · 296 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)

Keith T. Flaherty, Robert J. Gray, Alice P. Chen et al. · Journal of Clinical Oncology · 2020 · 295 citations · Full text

Medicine, Cancer Biology, Oncology +17

Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia

Yi‐Bin Chen, Shuli Li, Andrew A. Lane et al. · Biology of Blood and Marrow Transplantation · 2014 · 234 citations · Full text

Medicine, Hematology, Oncology +16